GlassScriptPhysician profile
Uche O Eneanya
NPI 1912020736
$512.79
in general payments reported to CMS, 2019-2025
13 companies · $60.09 in 2025
The $60.09 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $86.24 · 2022: $108 · 2023: $90.46 · 2024: $37.88 · 2025: $60.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $188.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $183.03 | 2019-2024 | Senza |
| Medtronic USA, INC. | $87.06 | 2019-2020 | |
| Medtronic, INC. | $42.40 | 2023 | Intellis Adaptivestim |
| Exact Sciences Corporation | $33.30 | 2023-2024 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $30.09 | 2025 | Abilify Asimtufii |
| Globus Medical, INC. | $30.00 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $17.25 | 2020 | |
| Pharmacosmos Therapeutics INC. | $16.74 | 2023 | Monoferric |
| Alkermes, INC. | $15.00 | 2019 | |
| Qol Medical, LLC | $15.00 | 2022 | |
| Merck Sharp & Dohme LLC | $15.00 | 2023 | Dificid |
| Kaleo, INC. | $14.99 | 2020 | |
| Glaxosmithkline, LLC. | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uche Eneanya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.